Heinz infant formula advert misleading, says ASA

By Jane Byrne

- Last updated on GMT

Related tags: Immune system, Nutrition

A complaint from viewers about a TV advert implying health claims with regard to a follow on formula from Heinz has been upheld by the UK’s Advertising Standards Authority (ASA).

The advert, which was broadcast in July 2008, was for the company’s follow-on formula, Nurture and included a voice-over stating that a baby needed a "special combination of nutrients to sustain the incredible growth in its brain, body and immune system,” with the Heinz formula developed to "provide for those three essential aspects of growth" by helping to "nourish, protect and develop your baby.”

The ASA concluded that Heinz's advert strategy implied a specific health benefit from the use of Nurture and as it was broadcast following the new Regulation 1924/2006/EC on health claims and nutrition for foods, the evidence submitted by the advertiser was not sufficiently robust to support the product’s claims in relation to children’s immunity and development:

We concluded, therefore, that the claim was unsubstantiated and the ad was unacceptable,”​ stated the voluntary watchdog.

A spokesperson for the ASA told NutraIngredients that it took 18 months to reach a ruling in the case due to its complexity, and the fact that due process had to take place as a result of there being the EC regulatory aspect to consider.

The ruling is a benchmark for future advertising in relation to the whole infant baby food sector. As a result of our thorough examination of this particular case, we hope that we can solve other cases of a similar nature more speedily,”​ he added.

Heinz, in defence of the advert, said that the claims for Nurture were based on the formula’s milk protein for growth and calcium for healthy teeth and bones in line with the compositional criteria for protein laid down in Commission Directive 2006/14/EC on Infant and Follow-on Formula.

The 'protect' claim came from constituents including iron, prebiotics and nucleotides that protect the immune system; and 'develop' came from the inclusion of omega-3 and omega-6, which helped brain and eye development.

Heinz, said that although the ‘protect’ claim had not been in use prior to the introduction of the Regulation, they believed it was appropriate for use during the transitional period and prior to a decision on its authorisation being made because in its view it described a general, non-specific benefit of the product.

The watchdog argued that, according to the requirements of the Regulation, only claims under children’s development and health that had been in compliance with national provisions before 19 January 2007 could be used during the transitional period, and thus only claims in relation to omega-3 and children’s development had been in accordance with UK national provisions prior to January 2007.

Related news

Show more

Related products

show more

Actilight® and infant nutrition: new perspectives

Actilight® and infant nutrition: new perspectives

Tereos | 31-Aug-2021 | Technical / White Paper

Addition of prebiotic ingredients to formulas started around 30 years ago and is widely recognized by experts. Actilight® scFOS is safe for use in infant...

Business case: private label iron supplements

Business case: private label iron supplements

PharmaLinea Ltd. | 18-May-2021 | Case Study

A line of clinically supported private label iron supplements by PharmaLinea is selling nearly 500.000 units/year in a market of under 20 million people.

Time to rethink your probiotics for infant use

Time to rethink your probiotics for infant use

Morinaga Milk Industry Co., Ltd. | 17-Sep-2020 | Technical / White Paper

Undoubtedly, probiotics-fortified infant nutrition products have hit the mainstream, and a baby-friendly concept is on the consumer radar. Morinaga's...

HRB probiotics: The gift of life for infant health

HRB probiotics: The gift of life for infant health

Morinaga Milk Industry Co., Ltd. | 29-Jun-2020 | Technical / White Paper

Bifidobacteria are among the first colonizers of human gut, and certain species are recognised as Human-Residential Bifidobacteria (HRB) - the natural...

Related suppliers

Follow us


View more